HR leadership
Economic reporting: zero illness absences observed during the pilot and €5.7k of modelled absenteeism savings, alongside a 58% continuation signal — all at cohort level.
WELLBEING AS A BENEFIT
Employees get a private, consumer-grade health experience. You get an anonymised analytics layer that translates cohort engagement into business outcomes — the only way both sides say yes.
Lewell x EDICOM, two-month pilot in Valencia, Spain. 24 employees enrolled across Rest & Mental Resilience and Sustainable Workload.
Lewell · Workforce insight
EDICOM — Pilot cohort, 24 employees
A missing check-in is treated as unknown, never as non-adherence. Cumulative reach grew to 20 of 24 employees by week 9.
Share of post-survey respondents agreeing (n=13). Reported as an end-of-pilot level, not a pre/post change.
Rest & Mental Resilience (Program B)
67%16 of 24 employees — 89% report greater wellbeing awareness, 64% want to continue
Sustainable Workload & Boundaries (Program C)
33%8 of 24 employees — 75% complete work within normal hours, 83% wake up rested
Mentions across 43 weekly responses. Time and forgetting dominate — which is why reminders and 5-minute actions matter more than longer content.
Weekly check-ins submitted per age band. Bands are wide enough to prevent re-identification.
Average annual salary of €26,817 (Valencia, all sectors, 2024) over 251 working days gives a daily cost of absence of €106.84. The Spanish medical-leave benchmark of 5.2% of contracted hours implies 2.24 sick days per employee over the 43 working days of the pilot, or 53.7 days across 24 employees. Zero illness absences were recorded, so the full 53.7 days are modelled as avoided: €5,733. This is an illustrative benchmark comparison, not an audited saving.
Want this dashboard populated with your own headcount and absence cost base? We build the model with you before the pilot starts.
Contact the teamEconomic reporting: zero illness absences observed during the pilot and €5.7k of modelled absenteeism savings, alongside a 58% continuation signal — all at cohort level.
Clinical credibility: the two pilot programs were built with an occupational health doctor and drawn from a library validated against NIOSH, WHO, JD-R and ergonomics guidance.
No behavioural or performance monitoring. Non-responses are treated as unknown, never as non-compliance, and results are only reported in aggregate.
Germany's Federal Institute for Occupational Safety and Health estimates €134B in lost production and €227B in lost gross value added from incapacity for work — the economic case for prevention is already made. Lewell makes it auditable.